Below are the top diagnostic substances stocks on the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at Nymox Pharmaceutical
NYMX is 90.50%. Nymox Pharmaceutical's revenue for the same period is $3.20 million.
The trailing-twelve-month return on equity at IDEXX Laboratories
IDXX is 44.30%. IDEXX Laboratories' operating margin for the same period is 19.60%.
The trailing-twelve-month return on equity at Meridian Bioscience
VIVO is 24.20%. Meridian Bioscience's PEG ratio is 1.78.
The trailing-twelve-month return on equity at Neogen
NEOG is 20.10%. Neogen's EPS for the same period is $0.75.
Loading...
Loading...
IDXXIDEXX Laboratories Inc
$653.95-1.50%
Edge Rankings
Momentum
85.91
Growth
79.66
Quality
50.14
Value
7.32
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
